Observed by APhA and ASHP since 2023, bipartisan support has garnered to give pharmacy workforce suicide awareness its own federally recognized day.
News|Slideshows|September 28, 2024
Small Doses: September 23 to September 27
Author(s)Lauren Massaro
Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.
Advertisement
Don’t get left behind: Sign up today for our
Advertisement
Related to this article
Atogepant reduced migraine days during the perimenstrual period, positioning the medication as a potential first treatment option for the condition.
Chad Worz, PharmD, BCGP, FASCP, discusses the Main Street Pharmacy Access Act, a revolutionary pharmacy-focused bill moving through Congress.
Data show that commercially and Medicaid-insured children with chronic or immunocompromising conditions incur 2- to 3-fold higher costs.
Researchers assess the neurological outcomes of over 200,000 children exposed to COVID-19 before birth.
Results show consistent improvements in wakefulness, cataplexy, and quality of life with oveporexton for patients with narcolepsy.
Researchers assess the differences in out-of-pocket spending on brand name compared with generic medication.
Practical takeaways to improve real‑world clinic outcomes for PAINWeek 2026.
Advertisement
Advertisement
Trending on Drug Topics
1
Johnson & Johnson Next Major Drugmaker to Require 340B Claims Data
2
Generic Drug Costs Burdening Patients as Much as Brand Name Options
3
Study Finds No Neurodevelopmental Risk in Prenatal COVID-19, Except Speech
4
How the Main Street Pharmacy Access Act Advances Pharmacist Provider Status
5